title: Hemophagocytic syndrome after living-related liver transplantation.
abstract: Hemophagocytic syndrome (HPS) is a life-threatening hematological disorder in immunocompromised patients. Although the number of patients with HPS following liver transplantation is scarce the outcome is usually fatal. We report a patient who developed HPS following living-related liver transplantation (LRLT) and was treated successfully by a combination of intravenous (IV) immunoglobulin (Ig) and granulocyte colony-stimulating factor (GCSF).
authors.affiliation: Department of Gastroenterology, Ege University, Izmir, Turkey. zekikarasu@hotmail.com
authors.forename: Z
authors.initials: Z
authors.lastname: Karasu
authors.forename: M
authors.initials: M
authors.lastname: Kilic
authors.forename: S
authors.initials: S
authors.lastname: Cagirgan
authors.forename: E
authors.initials: E
authors.lastname: Lebe
authors.forename: F
authors.initials: F
authors.lastname: Yilmaz
authors.forename: T
authors.initials: T
authors.lastname: Demirbas
authors.forename: Y
authors.initials: Y
authors.lastname: Tokat
mesh_terms: D000328:Adult; D001706:Biopsy; D003937:Diagnosis, Differential; D015614:Histiocytosis / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D006801:Humans; D016031:Liver Transplantation / Q000009:adverse effects* / Q000473:pathology; D019520:Living Donors; D008297:Male; D010956:Plasmapheresis